Drug Patent Expirations in July 2012

Drug Patent Expirations in July 2012

Drug Patent Expirations for July 2012

Tradename Applicant Generic Name Patent Number Patent Expiration
JEVTANA KIT Sanofi Aventis Us cabazitaxel 5698582 Jul 3, 2012
ISTODAX Celgene romidepsin 4977138 Jul 6, 2012
NEUROLITE Lantheus Medcl technetium tc-99m bicisate kit 5431900 Jul 11, 2012
CERVIDIL Controlled Therap dinoprostone 5269321 Jul 14, 2012
RESCULA Sucampo Pharms unoprostone isopropyl 5221763 Jul 15, 2012
MULTAQ Sanofi Aventis Us dronedarone hydrochloride 5223510 Jul 26, 2012
EVISTA Lilly raloxifene hydrochloride 6906086 Jul 28, 2012
EVISTA Lilly raloxifene hydrochloride RE38968 Jul 28, 2012
EVISTA Lilly raloxifene hydrochloride 5393763 Jul 28, 2012
EVISTA Lilly raloxifene hydrochloride RE39049 Jul 28, 2012
EVISTA Lilly raloxifene hydrochloride 5457117 Jul 28, 2012
LAMICTAL CD Glaxosmithkline lamotrigine 5698226*PED Jul 29, 2012
ETHYOL Medimmune amifostine 5424471 Jul 31, 2012
ETHYOL Medimmune amifostine 5591731 Jul 31, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • Moreā€¦
See the Database Preview and Plan Comparison. Contact Us with any questions.